Jones Robert S
Division of Pediatric Dentistry, Department of Developmental & Surgical Sciences, School of Dentistry, University of Minnesota, Minneapolis, MN 55455, USA.
J Clin Med. 2021 Mar 15;10(6):1212. doi: 10.3390/jcm10061212.
Alpha-adrenergic agonists, such as the Imidazoline derivatives (ImDs) of oxymetazoline and xylometazoline, are highly effective hemostatic agents. ImDs have not been widely used in dentistry but their use in medicine, specifically in ophthalmology and otolaryngology, warrants consideration for pulpal hemostasis. This review presents dental healthcare professionals with an overview of ImDs in medicine. ImD solutions have the potential to be more effective and biocompatible than existing topical hemostatic compounds in pulpal management. Through a comprehensive analysis of the pharmacology of ImDs and the microphysiology of hemostasis regulation in oral tissues, a conceptual model of pulpal management by ImD solutions is presented.
α-肾上腺素能激动剂,如羟甲唑啉和赛洛唑啉的咪唑啉衍生物(ImDs),是高效的止血剂。ImDs在牙科领域尚未得到广泛应用,但其在医学领域,特别是眼科和耳鼻喉科的应用,值得考虑用于牙髓止血。本综述向牙科保健专业人员概述了ImDs在医学中的应用。在牙髓管理方面,ImD溶液有可能比现有的局部止血化合物更有效且具有生物相容性。通过对ImDs的药理学和口腔组织止血调节的微观生理学进行全面分析,提出了ImD溶液牙髓管理的概念模型。